News & Media

Access press releases, presentations, and corporate information.

Press Room

News Releases

05/01/23

Neurocrine Biosciences Supports the Mental Health Community During Tardive Dyskinesia Awareness Week

04/12/23

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2023 Financial Results

04/12/23

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2023 Financial Results

03/21/23

Neurocrine Biosciences to Present at the Stifel 2023 CNS Days

03/21/23

Neurocrine Biosciences to Present at the Stifel 2023 CNS Days

03/09/23

Neurocrine Biosciences Announces Results from the Real-World RE-KINECT™ Study Published in the Journal of Patient-Reported Outcomes Demonstrating the Effects of Possible Tardive Dyskinesia (TD) on Patient Health and Social Functioning

03/09/23

Neurocrine Biosciences Presents Data on In Vitro Dissolution Performance of INGREZZA® (valbenazine) Capsule Contents via Soft Foods or Feeding Tube at AMDA - PALTC 2023 Annual Conference

Resources

About Neurocrine Biosciences

Learn About Us and Our Work

Clinical Studies

Check Out What We’re Studying

Pipeline

Check Out What We’re Working On